Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy

This publication has 17 references indexed in Scilit:

• Phase III radiation therapy oncology group (RTOG) trial 86-10 od androgen deprivation before and during radiotherapy in locally advanced carcinoma of the prostate
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY
  Urologic Clinics of North America, 1997
• Randomized, Prospective, Controlled Study Comparing Radical Prostatectomy Alone and Neoadjuvant Androgen Withdrawal in the Treatment of Localized Prostate Cancer
  Journal of Urology, 1996
• 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer
  Journal of Urology, 1995
• Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group
  Urology, 1995
• On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples From Clinical Oncology Data
  Journal of the American Statistical Association, 1993
• A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
  The Annals of Statistics, 1988
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958